FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045477579> ?p ?o ?g. }

• W2045477579 endingPage "241" @default.
• W2045477579 startingPage "233" @default.
• W2045477579 abstract "A series of previously undescribed 2,4-diamino-5-[2-methoxy-5-alkoxybenzyl]pyrimidines (3a-e) and 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines (3f-k) with up to eight CH2 groups in the alkoxy or omega-carboxyalkyloxy side chain were synthesized and tested for the ability to inhibit partially purified dihydrofolate reductase (DHFR) from Pneumocystis carinii (Pc), Toxoplasma gondii (Tg), Mycobacterium avium (Ma), and rat liver in comparison with two standard inhibitors, trimethoprim (1) and piritrexim (2). The latter drug is known to be extremely potent but shows a marked preference for binding to mammalian DHFR, whereas the former is very selective for the parasite enzymes but is a much weaker inhibitor. The underlying strategy for the synthesis of compounds 3a-k was that a hybrid structure embodying some features of both 1 and 2 might possess a more favorable combination of potency and selectivity than either parent drug. The choice of analogues 3f-k was based on the idea that the acidic omega-carboxyl group might interact preferentially with a basic center in the active site of DHFR from any of the parasite species relative to the active site of mammalian DHFR. In addition, the omega-carboxyl group was expected to improve water solubility relative to 1 or 2. In standardized spectrophotometric assays with dihydrofolate as the substrate and NADPH as the cofactor, 2,4-diamino-5-[(2-methoxy-4-carboxybutyloxy)benzyl]pyrimidine (3g) inhibited Pc DHFR with an IC(50) of 0.049 microM and rat DHFR with IC(50) of 3.9 microM. Its potency against Pc DHFR was 140-fold greater than that of 1 and close to that of 2, and its selectivity index, defined as the ratio IC(50)(rat liver)/IC(50)(P. carinii), was 8-fold higher than that of 1 and >10(4)-fold higher than that of 2. Although it was less potent and less selective against Tg than Pc DHFR, it was very potent as well as highly selective against Ma DHFR, with an IC(50) of 0.0058 microM and an IC(50)(rat liver)/IC(50)(M. avium) ratio of >600. Because of this favorable combination of potency and selectivity relative to 1 and 2, compound 3g may be viewed as a promising lead in the search for new antifolates with potential clinical activity against P. carinii and other opportunistic pathogens in patients with AIDS." @default.
• W2045477579 created "2016-06-24" @default.
• W2045477579 creator A5004578215 @default.
• W2045477579 creator A5041171666 @default.
• W2045477579 creator A5071627490 @default.
• W2045477579 date "2001-12-06" @default.
• W2045477579 modified "2023-10-01" @default.
• W2045477579 title "Inhibition of <i>Pneumocystis carinii</i>, <i>Toxoplasma </i><i>gondii</i>, and <i>Mycobacterium avium</i> Dihydrofolate Reductases by 2,4-Diamino-5-[2-methoxy-5-(ω-carboxyalkyloxy)benzyl]pyrimidines: Marked Improvement in Potency Relative to Trimethoprim and Species Selectivity Relative to Piritrexim" @default.
• W2045477579 cites W1818833536 @default.
• W2045477579 cites W1966428816 @default.
• W2045477579 cites W1979239212 @default.
• W2045477579 cites W1993326512 @default.
• W2045477579 cites W1994946938 @default.
• W2045477579 cites W2005748631 @default.
• W2045477579 cites W2014414662 @default.
• W2045477579 cites W2020333055 @default.
• W2045477579 cites W2021823360 @default.
• W2045477579 cites W2022331577 @default.
• W2045477579 cites W2025781604 @default.
• W2045477579 cites W2048740471 @default.
• W2045477579 cites W2053862404 @default.
• W2045477579 cites W2054758695 @default.
• W2045477579 cites W2055025009 @default.
• W2045477579 cites W2058654814 @default.
• W2045477579 cites W2060463809 @default.
• W2045477579 cites W2068174812 @default.
• W2045477579 cites W2100188798 @default.
• W2045477579 cites W2131963503 @default.
• W2045477579 cites W2136820849 @default.
• W2045477579 cites W2143294512 @default.
• W2045477579 cites W2163952229 @default.
• W2045477579 cites W2293171127 @default.
• W2045477579 cites W2318201169 @default.
• W2045477579 cites W2340948639 @default.
• W2045477579 cites W2342351290 @default.
• W2045477579 cites W279678372 @default.
• W2045477579 cites W1585229160 @default.
• W2045477579 doi "https://doi.org/10.1021/jm010407u" @default.
• W2045477579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11754594" @default.
• W2045477579 hasPublicationYear "2001" @default.
• W2045477579 type Work @default.
• W2045477579 sameAs 2045477579 @default.
• W2045477579 citedByCount "36" @default.
• W2045477579 countsByYear W20454775792012 @default.
• W2045477579 countsByYear W20454775792013 @default.
• W2045477579 countsByYear W20454775792014 @default.
• W2045477579 countsByYear W20454775792016 @default.
• W2045477579 countsByYear W20454775792019 @default.
• W2045477579 countsByYear W20454775792021 @default.
• W2045477579 countsByYear W20454775792022 @default.
• W2045477579 crossrefType "journal-article" @default.
• W2045477579 hasAuthorship W2045477579A5004578215 @default.
• W2045477579 hasAuthorship W2045477579A5041171666 @default.
• W2045477579 hasAuthorship W2045477579A5071627490 @default.
• W2045477579 hasConcept C134651460 @default.
• W2045477579 hasConcept C159047783 @default.
• W2045477579 hasConcept C159654299 @default.
• W2045477579 hasConcept C181199279 @default.
• W2045477579 hasConcept C185592680 @default.
• W2045477579 hasConcept C203014093 @default.
• W2045477579 hasConcept C2776275976 @default.
• W2045477579 hasConcept C2776980637 @default.
• W2045477579 hasConcept C2777559004 @default.
• W2045477579 hasConcept C2778128430 @default.
• W2045477579 hasConcept C2781320022 @default.
• W2045477579 hasConcept C2993443204 @default.
• W2045477579 hasConcept C3013748606 @default.
• W2045477579 hasConcept C41183919 @default.
• W2045477579 hasConcept C55493867 @default.
• W2045477579 hasConcept C71240020 @default.
• W2045477579 hasConcept C86803240 @default.
• W2045477579 hasConceptScore W2045477579C134651460 @default.
• W2045477579 hasConceptScore W2045477579C159047783 @default.
• W2045477579 hasConceptScore W2045477579C159654299 @default.
• W2045477579 hasConceptScore W2045477579C181199279 @default.
• W2045477579 hasConceptScore W2045477579C185592680 @default.
• W2045477579 hasConceptScore W2045477579C203014093 @default.
• W2045477579 hasConceptScore W2045477579C2776275976 @default.
• W2045477579 hasConceptScore W2045477579C2776980637 @default.
• W2045477579 hasConceptScore W2045477579C2777559004 @default.
• W2045477579 hasConceptScore W2045477579C2778128430 @default.
• W2045477579 hasConceptScore W2045477579C2781320022 @default.
• W2045477579 hasConceptScore W2045477579C2993443204 @default.
• W2045477579 hasConceptScore W2045477579C3013748606 @default.
• W2045477579 hasConceptScore W2045477579C41183919 @default.
• W2045477579 hasConceptScore W2045477579C55493867 @default.
• W2045477579 hasConceptScore W2045477579C71240020 @default.
• W2045477579 hasConceptScore W2045477579C86803240 @default.
• W2045477579 hasIssue "1" @default.
• W2045477579 hasLocation W20454775791 @default.
• W2045477579 hasLocation W20454775792 @default.
• W2045477579 hasOpenAccess W2045477579 @default.
• W2045477579 hasPrimaryLocation W20454775791 @default.
• W2045477579 hasRelatedWork W1961044295 @default.
• W2045477579 hasRelatedWork W2000024627 @default.
• W2045477579 hasRelatedWork W2011593151 @default.
• W2045477579 hasRelatedWork W2012882130 @default.
• W2045477579 hasRelatedWork W2049934743 @default.

• next